By Rebecca BoylePosted 06.27.2011 at 12:02 pm
A targeted snip through DNA’s double helix can take out a mutated gene that causes hemophilia, curing mice of the disease, a new study found. It’s the first study to use this form of genome editing in a living animal, and it could have implications for genetic treatment of other diseases, notably AIDS.
Scientists say the research is a major step forward for gene therapy, which has long promised to cure disease by editing genetic sequences.
The therapy is based on enzymes called zinc-finger nucleases, which serve as a sort of genetic scissors. The enzymes are engineered to match a specific gene location on a chromosome, where they snip through DNA’s double helix.
...
The study shows that zinc finger proteins and replacement genes can be used to induce changes in living animals, which is promising for a wide range of therapies. For instance, other researchers are using ZFNs to disrupt a gene that makes a receptor used by the AIDS virus, as the New York Times reports. People without that gene, CCR5, are naturally immune to HIV.
article
http://www.popsci.com/science/article/2011-06/genome-repair-kit-cures-blood-disorder-mice